COVID-19 vaccines finally are headed for more kids as U.S. regulators expanded use of Pfizer's shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class in the fall. Shots could begin within days once a federal vaccine advisory committee issues recommendations for using the two-dose vaccine in 12- to 15-year-olds.